Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07548307 · ClinicalTrials.gov registry record · NA
Radicle Revive™: A Study Assessing the Impact of Health and Wellness Products on Menopausal-Related Health Issues Associated Health Outcomes and Related Health Outcomes
A NA study, sponsored by Radicle Science.
- Recruiting
- Registry status
- NA
- Development phase
- 990
- Enrollment target
NCT07548307: Recruiting NA study, sponsored by Radicle Science.
NCT07548307 is a NA study that is actively recruiting participants, run by Radicle Science. The registered enrollment target is 990 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07548307, a NA study, is actively recruiting participants, sponsored by Radicle Science.
- RECRUITING
- Registry status
- NA
- Development phase
- 990 participants
- Enrollment target
Study Summary
Radicle Revive™: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on menopausal-related health issues associated health outcomes.
Primary Outcome
Change in cognitive function: Difference in rates of change over time in cognitive function score as assessed by PROMIS Cognitive Function 8A (scale 8-40; where lower scores correspond to worse cognitive function)
Interventions
- DIETARY_SUPPLEMENT Revive Product Placebo Control
- DIETARY_SUPPLEMENT Revive Active Product 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 990 participants |
| Start Date | 2026-04-09 |
| Est. Completion | 2027-04-07 |
| Phase | NA |
What NCT07548307 shows while recruiting
NCT07548307 is an interventional study that assigns participants to a tested intervention. The registered 990 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 2 interventions - of which Revive Product Placebo Control is the first listed.
NCT07548307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07548307 about?
NCT07548307 is a clinical study titled "Radicle Revive™: A Study Assessing the Impact of Health and Wellness Products on Menopausal-Related Health Issues Associated Health Outcomes and Related Health Outcomes". Radicle Revive™: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on menopausal-related health issues associated health outcomes.
What is the current status of trial NCT07548307?
This trial is currently recruiting. It is a NA study. The enrollment target is 990 participants. The study started on 2026-04-09. Estimated completion is 2027-04-07.
What interventions are being tested in trial NCT07548307?
The interventions under investigation include: Revive Product Placebo Control (DIETARY_SUPPLEMENT), Revive Active Product 1 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07548307?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07548307's enrollment target sits among peer trials
990 121st of 2000 higher than 1,879 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- NCT06883305 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI